Financial

Brokerage Recent Rating Update: Hudson Technologies, Inc. (NASDAQ:HDSN) , Cascadian Therapeutics, Inc (NASDAQ:CASC)

0 71

Hudson Technologies, Inc. (NASDAQ:HDSN) initiated the shares trading at $5.43 and showed positive change of +1.10% while the stock’s final trade was registered at $ 5.49. However, its previous closing price was seen at $5.43. The stock negotiated total number of 758.24 thousand shares as compared to 3 months average volume of 480.91 thousand shares.

The stock price demonstrated downbeat change from its 50 day moving average of 4.62 and had been up from its 200 Day Moving Average of 3.68.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. One week ago, shares have been suggested as “BUY” from “0” brokerage firms and recommended as “Strong Buy” by “4” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “0” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 1 based on consensus of the brokerage firms issuing ratings.

The average true range of Hudson Technologies Inc.’s (HDSN) is recorded at 0.29 and the relative strength index of the stock stands 69.36. The stock price is going above to its 52 week low with 124.08% and lagging behind from its 52 week high with -2.49%. Analyst recommendation for this stock stands at 1.80. A look on the firm performance, its monthly performance is 9.15% and a quarterly performance of 61.95%. The stock price is trading upbeat from its 200 days moving average with 59.35% and up from 50 days moving average with 30.69%.

Shares of Cascadian Therapeutics, Inc (NASDAQ:CASC) climbed +3.48% and ended at $1.19 greater than previous closing price of $1.15. The total 431.55 thousand shares were bought and sold throughout the most recent trading session less than average volume of 931.23 thousand shares.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. One week ago, shares have been suggested as “BUY” from “1” brokerage firms and recommended as “Strong Buy” by “2” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “0” brokerage firms. “1” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 1.75 based on consensus of the brokerage firms issuing ratings.

Cascadian Therapeutics, Inc.’s (CASC) has price-to-cash ratio of 1.97 .A look on the firm performance, its monthly performance is 4.39% and a quarterly performance of 9.17%. The stock price is moving up from its 20 days moving average with 6.73% and isolated positively from 50 days moving average with 12.31%.

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter